|
ENST00000710424.1
|
ENST00000710424.1_2046_2067_+ |
2046–2067 |
69.00 |
0.08 |
0.20 |
100.0 |
MIR17HG-214
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000710424.1
|
ENST00000710424.1_2069_2124_+ |
2069–2124 |
23.00 |
0.03 |
0.07 |
100.0 |
MIR17HG-214
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000710424.1
|
ENST00000710424.1_1873_1895_+ |
1873–1895 |
29.00 |
0.03 |
0.08 |
100.0 |
MIR17HG-214
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000710424.1
|
ENST00000710424.1_1419_1441_+ |
1419–1441 |
53.00 |
0.06 |
0.15 |
100.0 |
MIR17HG-214
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718227.1
|
ENST00000718227.1_356_384_+ |
356–384 |
4056.00 |
2.22 |
11.83 |
100.0 |
SNHG32-223
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718227.1
|
ENST00000718227.1_387_419_+ |
387–419 |
343.00 |
0.19 |
1.00 |
100.0 |
SNHG32-223
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718227.1
|
ENST00000718227.1_359_419_+ |
359–419 |
39.00 |
0.02 |
0.11 |
100.0 |
SNHG32-223
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718227.1
|
ENST00000718227.1_352_421_+ |
352–421 |
1458.00 |
0.80 |
4.25 |
67.28 |
SNHG32-223
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718227.1
|
ENST00000718227.1_356_419_+ |
356–419 |
174943.00 |
95.58 |
510.31 |
100.0 |
SNHG32-223
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718231.1
|
ENST00000718231.1_1950_2016_+ |
1950–2016 |
31516.00 |
95.32 |
91.93 |
98.91 |
SNHG32-227
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718231.1
|
ENST00000718231.1_1988_2016_+ |
1988–2016 |
239.00 |
0.72 |
0.70 |
100.0 |
SNHG32-227
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718231.1
|
ENST00000718231.1_1955_2016_+ |
1955–2016 |
17.00 |
0.05 |
0.05 |
100.0 |
SNHG32-227
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718231.1
|
ENST00000718231.1_1964_2016_+ |
1964–2016 |
6.00 |
0.02 |
0.02 |
100.0 |
SNHG32-227
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000718311.1
|
ENST00000718311.1_841_855_+ |
841–855 |
173.00 |
57.28 |
0.50 |
100.0 |
B4GALT1-203
|
nonsense mediated decay
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000722183.1
|
ENST00000722183.1_57_79_+ |
57–79 |
1084.00 |
6.45 |
3.16 |
100.0 |
ENST00000722183
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000722183.1
|
ENST00000722183.1_143_158_+ |
143–158 |
691.00 |
4.11 |
2.02 |
71.31 |
ENST00000722183
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000722183.1
|
ENST00000722183.1_126_158_+ |
126–158 |
339.00 |
2.02 |
0.99 |
100.0 |
ENST00000722183
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000726427.1
|
ENST00000726427.1_819_841_+ |
819–841 |
14.00 |
38.89 |
0.04 |
100.0 |
MIR34BHG-202
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000730292.1
|
ENST00000730292.1_241_262_+ |
241–262 |
5590.00 |
79.20 |
16.31 |
84.33 |
THBS3-AS1-228
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000732834.1
|
ENST00000732834.1_2132_2152_+ |
2132–2152 |
3.00 |
14.29 |
0.01 |
100.0 |
MIR200CHG-202
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000732834.1
|
ENST00000732834.1_1719_1741_+ |
1719–1741 |
3.00 |
14.29 |
0.01 |
100.0 |
MIR200CHG-202
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000738116.1
|
ENST00000738116.1_64_138_+ |
64–138 |
13962.00 |
84.10 |
40.73 |
100.0 |
SNHG16-266
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000738116.1
|
ENST00000738116.1_111_138_+ |
111–138 |
326.00 |
1.96 |
0.95 |
100.0 |
SNHG16-266
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000738116.1
|
ENST00000738116.1_64_97_+ |
64–97 |
281.00 |
1.69 |
0.82 |
100.0 |
SNHG16-266
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000738116.1
|
ENST00000738116.1_88_138_+ |
88–138 |
134.00 |
0.81 |
0.39 |
100.0 |
SNHG16-266
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|